at Hammersmith Hospital
Private leukaemia treatment
Our leukaemia unit at Hammersmith Hospital is one of the world’s leading centres for the diagnosis and treatment of leukaemia and blood cancers.
Established in 1970 as the MRC Leukaemia Unit, we offer a range of traditional and new treatments and have pioneered new standards of care through our fully developed research programme.
As one of our private cancer patients you will benefit from:
• Treatment at a world-leading centre at the forefront of research into leukaemia and blood cancers.
• Expertise in personalised medicine so that we choose and provide the best treatment for you and your condition.
• Access to new drugs and leading-edge treatments due to our involvement in a broad programme of trials.
• Treatment led by a highly specialised consultant who is involved in the latest research. They will oversee every detail of your care and all treatment decisions.
• Care delivered by a large multi-disciplinary team led by your consultant who work closely together to provide the best treatment tailored to your condition.
• Modern and comfortable private facilities
As our cancer patient you will receive a rapid diagnosis, making immediate treatment as an inpatient or outpatient possible.
Accurate diagnosis is essential for successful treatment and we are proud of our in-house diagnostic service which has brought into practice many of the advances in diagnosis and monitoring of leukaemia.
We perform a range of tests on blood and bone marrow samples which look for abnormal levels of blood cells, for molecular changes in the blood and genetic testing for abnormalities in chromosomes and DNA.
Other specialist tests look for certain characteristics in cancer cells to determine the treatment most suited to your condition.
These techniques are also essential in monitoring the effectiveness of your treatment so we can offer truly individualised therapy and check for recurrence of the disease. Some of our techniques, which look for the very tiny presence of cancer cells remaining after treatment and transplantation, are not widely available
As a patient of Imperial Private Healthcare, you will have access to the most effective treatment available for all types of leukaemia. We believe in personalised therapy and take every possible step to choose the most appropriate treatment.
You will be able to discuss your proposed treatment plan in detail with your consultant and multidisciplinary team. With your permission and if they wish, we can also discuss this with your relatives and friends. We proceed with treatment only once we have your fully informed consent.
We offer a broad range of traditional and new, cutting-edge therapies including:
- targeted therapies to attack specific cancer cells without damaging normal cells
- immunotherapies to stimulate the immune system to fight cancer
- bone marrow transplants
After treatment we closely monitor residual disease (the small number of cancer cells which remain) and this is important in further treatment decisions.
Depending on your type of leukaemia or blood cancer, you will have access to these treatment options:
Acute lymphoblastic leukaemia (ALL)
- The full range of inpatient and outpatient treatments including traditional chemotherapy, targeted therapies and haematopoietic stem cell transplantation.
- We are able to offer this transplant even to patients who do not have a fully matched donor and are one of the most experienced centres in the world in performing these transplants.
Acute myeloid leukaemia (AML)
- Intensive chemotherapy and more gentle therapy options on an inpatient and outpatient basis. Blood and bone marrow transplantation is often used.
- We have an active research programme into AML and transplantation, and our private patients may benefit from trials of new treatments.
Chronic lymphocytic leukaemia (CLL)
- Chemotherapy in tablet or infusion form, and targeted therapies. We are involved in clinical trials which increases the treatment options available to our private patients.
Chronic myeloid leukaemia (CML)
- Targeted therapy with various drugs, many developed at our leukaemia unit, and haematopoietic stem cell transplantation.
- Selection of the best therapy for each individual patient is based on a number of scientific factors.
- Myelodysplastic syndromes – a group of blood cancers in which the bone marrow does not make enough healthy blood cells
- We offer all treatment options including gentle or intensive chemotherapy and haematopoietic stem cell transplantation.
- Myeloproliferative neoplasms – a group of blood cancers in which the body makes too many blood cells
- We offer all treatment options from oral chemotherapy and targeted therapy to hematopoietic stem cell transplantation in patients with advanced forms of the disease.